NFE2L2 is detected as a mutational cancer driver in Bladder Urothelial Carcinoma
NFE2L2 reports in Bladder Urothelial Carcinoma (BLCA)
Cancer type details
Bladder Urothelial Carcinoma |
---|
Cohorts
8
Samples 905 Mutations 6,585,575 Driver genes 89 |
Gene details
NFE2L2 |
---|
Ensembl ID
ENSG00000116044
Transcript ID ENST00000397062 Protein ID ENSP00000380252 |
Cohorts where is driver
3
Mutated samples 37 Mutated samples (%) 4.09 Mutations 45 |
Mode of action Ambiguous |
Known driver True |
Method signals per Cohort
Cohort | Methods | Samples | Samples (%) |
---|
In-silico saturation mutagenesis
Model | Mutations | Driver mutations | Driver mutations (%) |
---|---|---|---|
BLCA (Bladder Urothelial Carcinoma) | 5436 | 829 | 15.25 |
Observed mutations in tumors
Mutation (GRCh38) | Protein Position | Samples | Samples (%) | Consequence | Driver | Driver score |
---|